kaiser permanente and glp 1 GLP-1 medications are changing the conversation around weight loss — but they are not the whole story., “The secret to their success wasn’t one drug.”, In this episode of PermanenteDocs Chat, Alex A New Medicare Option for

El enfoque no es corregir el tratamiento, sino acompaar a tu cuerpo con las herramientas adecuadas , desde la alimentacin hasta la suplementacin consciente y guiada

GLP-1 receptors are expressed in the heart muscle cells, immune system cells in the heart, and in the lining of blood vessels.[ref] GLP-1 RAs have been shown to help in heart failure and also to have beneficial effects on heart rhythm.[ref] Related article : Cardiovascular disease genetic risk factors Cancer Research: Retatrutide, a GLP-1/GIP/GCG triple agonist, has recently been shown to reduce pancreatic tumor mass in animals

Both medications are suitable for individuals who: Have a BMI of 30 or higher (obesity)

The SELECT trial showed a 20% reduction in MACE with semaglutide in people with overweight/obesity and established CVD